Skip to search formSkip to main contentSkip to account menu

ramelteon

Known as: (S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide, ramelteon [Chemical/Ingredient] 
A synthetic melatonin analogue with hypnotic and circadian rhythm-modulating activities. Ramelteon binds to and activates melatonin receptors 1 and 2… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (1)

Indenes
Ramelteon M-II:MCnt:Pt:Tiss:QnRamelteon:MCnc:Pt:Ser/Plas:Qnramelteon 8 MG Oral Tablet [Rozerem]

Narrower (2)

RozeremTAK-375

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Adjunctive treatment with melatonin receptor agonists for older delirious patients with the sundowning phenomenon.
A 75-year-old man with Alzheimer dementia (Mini Mental State Examination score = 15) had been followed for 1 year. His behaviour… 
2014
2014
Synthesis of new melatoninergic hexahydroindenopyridines.
Review
2012
Review
2012
Augmentation with ramelteon to achieve remission in geriatric major depression
of ‘evil eyes’, which had been elaborated by auditory hallucinations. He said: ‘I could not pluck out my own eyes, which had been… 
2011
2011
Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
2009
2009
Health before profits? Learning from Thailand's experience
Review
2007
Review
2007
Update on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary care.
OBJECTIVE From a safety perspective, several issues require assessment when a decision is made to prescribe a sleep medication… 
Review
2007
Review
2007
New perspectives for the treatment of disorders of sleep and arousal.
2007
2007
Melatonin, Sleep, and Sleep Disorders
2006
2006
Ramelteon (Rozerem) for insomnia.
Ramelteon is safe and effective for decreasing the time to persistent sleep in patients with chronic insomnia. It does not have… 
2005
2005
Ramelteon: A novel melatonin receptor agonist for the treatment of insomnia
Ramelteon (Takeda Pharmaceuticals) is a selective melatonin receptor agonist awaiting FDA approval for the treatment of insomnia… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)